Skip to main content
Log in

Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Teicoplanin in a 400 mg intravenous loading dose followed by 200 mg/day intravenously or intramuscularly was given to 19 patients with deep-seated staphylococcal infections. Only eight patients (44.4 %) were considered cured, failure mostly being observed in patients with osteomyelitis, endocarditis and bacteremia. Poor tissue kinetics of teicoplanin and the presence of foreign bodies are probable explanations for the reported failures. Future trials using a higher dose of teicoplanin with or without the addition of rifampicin or gentamicin seem to be justified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pallanza, R., Berti, M., Goldstein, B. P., Mapelli, E., Randisi, E., Scotti, R., Arioli, V. Teichomycin: in vitro and in vivo evaluation in comparison with other antibiotics. Journal of Antimicrobial Chemotherapy 1983, 11: 419–425.

    Google Scholar 

  2. Neu, H. C., Labthavikul, P. In vitro activity of teichomycin compared with those of other antibioticis. Antimicrobial Agents and Chemotherapy 1983, 24: 425–428.

    Google Scholar 

  3. Williams, A. H., Gruneberg, R. N. Teicoplanin. Journal of Antimicrobial Chemotherapy 1984, 14: 441–445.

    Google Scholar 

  4. Verbist, L., Tjandramaga, T. B., Van Hecken, A., Van Melle, P., Verbesselt, R., De Schepper, R. J. Pharmacokinetics and bioavailability of intravenous and intramuscular teicoplanin in normal volunteers. Antimicrobial Agents and Chemotherapy 1984, 26: 881–886.

    Google Scholar 

  5. Chambers, H. F., Sande, M. A. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or resistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy 1984, 26: 61–64.

    Google Scholar 

  6. Sullam, P. M., Tauber, M. G., Hackbarth, C. J., Sande, M. A. Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis. Antimicrobial Agents and Chemotherapy 1985, 27: 135–136.

    Google Scholar 

  7. Kosmidis, J., Kastanakis, S. Teicoplanin, a new glycopeptide antibiotic. In vitro activity, pharmacokinetic studies and therapeutic efficacy in gram positive infections. Chemioterapia 1985, 452: 695–696.

    Google Scholar 

  8. Bauer, A. W., Kirby, W. M., Sherris, J. C., Turck, M. Antibiotic susceptibility testing by a standardized single-disk method. American Journal of Clinical Pathology 1966, 36: 493–496.

    Google Scholar 

  9. Jones, R. N., Barry, A. L., Gavan, T. L., Washington, J. A. Susceptibility tests: microdilution and macrodilution broth procedures. In: Lennette, E. H., Balows, A., Hausler, W. J., Shadomy, H. J. (ed.): Manual of clinical microbiology. American Society for Microbiology, Washington, DC, 1985, p. 972–977.

    Google Scholar 

  10. Reller, R. B., Stratton, C. W. Serum dilution test for bacteridical activity. II: Standardization and correlation with antimicrobial assays and susceptibility tests. Journal of Infectious Diseases 1977, 136: 196–204.

    Google Scholar 

  11. Giamarellou, H., Papapetropoulou, M., Daikos, G. K. Methicillin-resistantStaphylococcus aureus infections during 1978–79: clinical and bacteriologic observations. Journal of Antimicrobial Chemotherapy 1981, 7: 649–655.

    Google Scholar 

  12. Karchmer, A. W. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Annals of Internal Medicine 1985, 78, Supplement 6B: 116–127.

    Google Scholar 

  13. Van Laethem, Y., Goosens, H., Cran, S., Butzler, J. P., Jaspar, N., Clumeck, N.: Clinical efficacy of teicoplanin alone in severe methicillin-resistant gram positive septicemia. In: Ishigami, J. (ed.): Recent advances in chemotherapy: antimicrobial section. Proceedings of the 14th International Congress of Chemotherapy. University of Tokyo Press, 1985, p. 1907–1908.

  14. Calain, P., Krause, K. H., Vandaux, P., Auckenthaler, R., Lew, D., Waldvogel, F., Hirsotel, B. Early termination of a prospective randomised trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. Journal of Infectious Diseases 1987, 155: 187–191.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galanakis, N., Giamarellou, H., Vlachogiannis, N. et al. Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 7, 130–134 (1988). https://doi.org/10.1007/BF01963065

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01963065

Keywords

Navigation